1. Home
  2. OFLX vs GLSI Comparison

OFLX vs GLSI Comparison

Compare OFLX & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omega Flex Inc.

OFLX

Omega Flex Inc.

HOLD

Current Price

$25.96

Market Cap

266.9M

Sector

Industrials

ML Signal

HOLD

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

SELL

Current Price

$16.28

Market Cap

255.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OFLX
GLSI
Founded
1975
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
266.9M
255.5M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
OFLX
GLSI
Price
$25.96
$16.28
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $57.00
AVG Volume (30 Days)
39.0K
★ 123.2K
Earning Date
10-28-2026
11-17-2026
Dividend Yield
★ 5.13%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.70
N/A
Revenue
★ $98,296,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$37.74
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$23.99
$7.78
52 Week High
$37.92
$34.10

Technical Indicators

Market Signals
Indicator
OFLX
GLSI
Relative Strength Index (RSI) 56.04 46.07
Support Level $24.67 $14.44
Resistance Level $26.97 $19.97
Average True Range (ATR) 0.95 1.20
MACD 0.23 0.06
Stochastic Oscillator 67.29 29.67

Price Performance

Historical Comparison
OFLX
GLSI

About OFLX Omega Flex Inc.

Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.

Share on Social Networks: